LUBRICATING NASAL MIST 20 %
PROPYLENE GLYCOL : 20 % MACROGOL : 15 % · DIN 00551813 · PHARMASCIENCE INC
Health Canada status: CANCELLED POST MARKET
What is LUBRICATING NASAL MIST?
LUBRICATING NASAL MIST 20 % contains PROPYLENE GLYCOL : 20 % MACROGOL : 15 %. It is listed in the Health Canada Drug Product Database under DIN 00551813, held by PHARMASCIENCE INC, supplied as METERED-DOSE AEROSOL for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Oct-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00551813 |
|---|---|
| Brand name | LUBRICATING NASAL MIST |
| Generic / active ingredient | PROPYLENE GLYCOL : 20 % MACROGOL : 15 % |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 20 % |
| Dosage form | METERED-DOSE AEROSOL |
| Route of administration | NASAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AX10 VARIOUS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Oct-2025 |
What can be used instead?
Other Canadian products sharing ATC code R01AX10 VARIOUS. 3 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| RHINARIS NASAL GEL | 15 % | GEL | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02352699 |
| RHINARIS NASAL MIST | 5 % | SPRAY, METERED DOSE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02354551 |
| SECARIS | 15 % | GEL | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00551805 |
| AIRLIFE STERILE WATER FOR INHALATION USP | 100 % | LIQUID | CARDINAL HEALTH MEDICAL PRODUCTS AND SERVICES | CANCELLED POST MARKET | DIN 00790117 |
| DEY-PAK SODIUM CHLORIDE SOLUTION 0.45% | .45 % | SOLUTION | DEY PHARMA L.P. | CANCELLED POST MARKET | DIN 02058227 |
| DEY-PAK SODIUM CHLORIDE SOLUTION 10% | 10 % | SOLUTION | DEY PHARMA L.P. | CANCELLED POST MARKET | DIN 02058243 |
| DEY-PAK SODIUM CHLORIDE SOLUTION 3% | 3 % | SOLUTION | DEY PHARMA L.P. | CANCELLED POST MARKET | DIN 02058251 |
| LUBRICATING NASAL GEL | 15 % | GEL | PHARMASCIENCE INC | DORMANT | DIN 02220806 |
| LUBRICATING NASAL MIST | 15 % | METERED-DOSE AEROSOL | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00732230 |
| RHINEDRINE LUBRICANT NASAL GEL | 15 % | GEL | JAMIESON LABORATORIES LTD | CANCELLED POST MARKET | DIN 02078937 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.